These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7616117)
1. Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome. Batta AK; Tint GS; Shefer S; Abuelo D; Salen G J Lipid Res; 1995 Apr; 36(4):705-13. PubMed ID: 7616117 [TBL] [Abstract][Full Text] [Related]
2. Cholesta-5,7,9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. De Fabiani E; Caruso D; Cavaleri M; Galli Kienle M; Galli G J Lipid Res; 1996 Nov; 37(11):2280-7. PubMed ID: 8978479 [TBL] [Abstract][Full Text] [Related]
3. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Rossiter JP; Hofman KJ; Kelley RI Am J Med Genet; 1995 Apr; 56(3):272-5. PubMed ID: 7778588 [TBL] [Abstract][Full Text] [Related]
4. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. Tint GS; Irons M; Elias ER; Batta AK; Frieden R; Chen TS; Salen G N Engl J Med; 1994 Jan; 330(2):107-13. PubMed ID: 8259166 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Kelley RI Clin Chim Acta; 1995 Apr; 236(1):45-58. PubMed ID: 7664465 [TBL] [Abstract][Full Text] [Related]
6. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome. Batta AK; Salen G; Tint GS; Shefer S J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079 [TBL] [Abstract][Full Text] [Related]
7. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata. Rakheja D; Boriack RL Pediatr Dev Pathol; 2008; 11(2):128-32. PubMed ID: 17378665 [TBL] [Abstract][Full Text] [Related]
8. Smith-Lemli-Opitz syndrome: biochemical before clinical diagnosis; early dietary management. Nwokoro NA; Hyde B; Mulvihill JJ Am J Med Genet; 1994 May; 50(4):375-6. PubMed ID: 8209919 [TBL] [Abstract][Full Text] [Related]
9. A reliable tool for detecting 7-dehydrocholesterol and cholesterol in human plasma and its use in diagnosis of Smith-Lemli-Opitz syndrome. Luo Y; Liu Z; Zeng Y; Zhang Y; Luan Y; Ma L; Chen L; Zou L; Yang J; Huang Z; Rao Y; Zhang C J Sep Sci; 2022 Mar; 45(5):1080-1093. PubMed ID: 34962712 [TBL] [Abstract][Full Text] [Related]
10. Abnormal bile acids in the Smith-Lemli-Opitz syndrome. Natowicz MR; Evans JE Am J Med Genet; 1994 May; 50(4):364-7. PubMed ID: 8209917 [TBL] [Abstract][Full Text] [Related]
11. Sterols in blood of normal and Smith-Lemli-Opitz subjects. Ruan B; Wilson WK; Pang J; Gerst N; Pinkerton FD; Tsai J; Kelley RI; Whitby FG; Milewicz DM; Garbern J; Schroepfer GJ J Lipid Res; 2001 May; 42(5):799-812. PubMed ID: 11352988 [TBL] [Abstract][Full Text] [Related]
12. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome. Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767 [TBL] [Abstract][Full Text] [Related]
13. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648 [TBL] [Abstract][Full Text] [Related]
14. Desmosterolosis and desmosterol homeostasis in the developing mouse brain. Allen LB; Genaro-Mattos TC; Porter NA; Mirnics K; Korade Z J Inherit Metab Dis; 2019 Sep; 42(5):934-943. PubMed ID: 30891795 [TBL] [Abstract][Full Text] [Related]
15. Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry. Seedorf U; Fobker M; Voss R; Meyer K; Kannenberg F; Meschede D; Ullrich K; Horst J; Benninghoven A; Assmann G Clin Chem; 1995 Apr; 41(4):548-52. PubMed ID: 7720244 [TBL] [Abstract][Full Text] [Related]
16. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Irons M; Elias ER; Tint GS; Salen G; Frieden R; Buie TM; Ampola M Am J Med Genet; 1994 May; 50(4):347-52. PubMed ID: 8209913 [TBL] [Abstract][Full Text] [Related]
17. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome. Ruan B; Tsai J; Wilson WK; Schroepfer GJ J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346 [TBL] [Abstract][Full Text] [Related]
18. [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia]. GarcíaFuentes E; icioso Recio MV ; del Castillo Acedo Del Olmo E ; atas Jurado MM ; Arana Agüera M ; López López J An Esp Pediatr; 2000 Nov; 53(5):482-7. PubMed ID: 11141372 [TBL] [Abstract][Full Text] [Related]
19. [Historical aspects of the Smith-Lemli-Opitz syndrome]. Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692 [TBL] [Abstract][Full Text] [Related]
20. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients. Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]